Picture of Avicanna logo

AVCN Avicanna Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Avicanna, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
C2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16.8-14.7-8.74-4.58-2.76
Depreciation
Deferred Taxes
Non-Cash Items6.634.982.21.620.891
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2.451.434.36-0.438-0.056
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities-11.7-7.44-1.4-2.55-1.18
Capital Expenditures-0.789-0.067-0.558-0.403-0.256
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1.550.877-2.4900
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Cash from Investing Activities0.7610.81-3.05-0.403-0.256
Financing Cash Flow Items-0.0680.7610.770.3270.076
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities10.19.93.553.420.963
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.241.16-0.717-0.029-0.167